Killing the Golden Goose of US Drug Innovation: Drug Pricing Myths (Part II)

1 min

In September 2025, Brandon Phemester published Killing the Golden Goose of U.S. Drug Innovation: Drug Pricing Myths (Part II) in Life Sciences IP Review (LIPR). Click here to read.